Researchers at Texas A&M report a method delivered through the nose that appears to improve brain repair and reduce signs of aging in animal models. The delivery route, the biological targets, and the duration of benefit are important because they determine whether a therapy is practical, scalable, and equitable. Treatments that avoid invasive surgery and can be administered outside hospitals may expand access, but safety, dosing, and long-term effects all matter before clinical use.
The intriguing lab results raise many questions about how this approach would translate to people and what it implies for treating age-related cognitive decline. Read the full article to learn which mechanisms the team targeted and how their findings might influence future research on maintaining brain health, supporting independence, and designing inclusive clinical trials that reflect diverse aging experiences.
Scientists from Texas A&M University have developed a nasal spray that can reverse brain aging, potentially changing the future of age-rated brain therapies. The team led by Ashok K. Shetty, associate director of the Institute for Regenerative Medicine, developed a nasal…
